Induction of cyclin-dependent kinase inhibitor p21 in vesnarinone-induced differentiation of squamous cell carcinoma cells

Cancer Letters

Volumn 133, Issue 1, 1998, Pages 35-45

  Yoneda, Kazunori ^a   Yamamoto, Tetsuya ^a   Ueta, Eisaku ^a   Osaki, Tokio ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Differentiation; G1 arrest; p21; p53; Squamous cell carcinoma cells; Vesnarinone

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; MESSENGER RNA; PIPERANOMETOZINE; PROTEIN P21; PROTEIN P53;

ARTICLE; CELL CULTURE; CELL CYCLE; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MUTANT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CYCLIN E; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; G1 PHASE; HUMANS; MOUTH NEOPLASMS; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); QUINOLINES; RETINOBLASTOMA PROTEIN; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032418838     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00187-6     Document Type: Article

References (44)

1. Wyllie A.H., Kerr J.F., Currie A.R. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68:1980;251-306.
2. Gottlieb T.M., Oren M. p53 in growth control and neoplasia. Biochim. Biophys. Acta. 1287:1996;77-102.
3. Levine A.J. p53 the cellular gatekeeper for growth and division. Cell. 88:1997;323-331.
4. Dulic V., Kaufmann W.K., Wilson S.J., et al. p53-dependent inhibition of cyclin dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell. 76:1994;1013-1023.
5. Ikeda M., Jakoi J., Nevins J.R. A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation. Proc. Natl. Acad. Sci. USA. 93:1996;3215-3220.
6. Harper J.W., Adami G.R., Wei N., Keyomarsi K., Elledge S.J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 75:1993;805-816.
7. Gu Y., Turck C.W., Morgan D.O. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature. 366:1993;707-710.
8. Xiong Y., Hannon G.J., Zhang H., Casso D., Kobayashi R., Beach D. p21 is a universal inhibitor of cyclin kinases. Nature. 366:1993;701-704.
9. Hartwell L.H., Kastan M.B. Cell cycle control and cancer. Science. 266:1994;1821-1828.
10. Weinberg R.A. The retinoblastoma protein and cell cycle control. Cell. 81:1995;323-330.
11. El-Deiry W.S., Tokino T., Velculescu V.E., et al. WAF1, a potential mediator of p53 tumor suppression. Cell. 75:1993;817-825.
12. Jiang H., Lin J., Su Z.Z., Collart F.R., Huberman E., Fisher P.B. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene. 9:1994;3397-3406.
13. Steinman R.A., Hoffman B., Iro A., Guillouf C., Liebermann D.A., El-Houseini M.E. Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene. 9:1994;3389-3396.
14. Halevy O., Novitch B.G., Spicer D.B., et al. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by Myo D. Science. 267:1995;1018-1021.
15. Parker S.B., Eichele G., Zhang P., et al. p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science. 267:1995;1024-1027.
16. Skapek S.X., Rhee J., Spicer D.B., Lassar A.B. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science. 267:1995;1022-1024.
17. Sato M., Kawamata H., Harada K., et al. Induction of cyclin-dependent kinase inhibitor, p21WAF1, by treatment with 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinoline (vesnarinone) in a human salivary cancer cell line with mutant p53 gene. Cancer Lett. 112:1997;181-189.
18. Skladanowski A., Larsen A.K. Expression of wild-type p53 increases etoposide cytotoxicity in M1 myeloid leukemia cells by facilitated G2 to M transition: implications for gene therapy. Cancer Res. 57:1997;818-823.
19. Waldman T., Lengauer C., Kinzler K.W., Vogelstein B. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature. 381:1996;713-716.
20. Bergh G., Ehinger M., Olofsson T., et al. Altered expression of the retinoblastoma tumor-suppressor gene in leukemia cell lines inhibits induction of differentiation but not G1-accumulation. Blood. 89:1997;2938-2950.
21. Sacchi S., Russo D., Avvisati G., et al. All-trans retinoic acid in hematological malignancies, an update. GER (Gruppo Ematologico Retinoidi). Haematologica. 82:1997;106-121.
22. Sato M., Yoshida H., Kaji R., et al. Induction of bone formation in an adenoid cystic carcinoma of the maxillary sinus by adoptive immunotherapy involving intra-arterial injection of lymphokine-activated killer cells and recombinant interleukin-2 in combination with radiotherapy. J. Biol. Response Mod. 9:1990;329-334.
23. Ueta E., Osaki T., Yamamoto T., Yoneda K. Induction of differentiation in maxillary adenoid cystic carcinomas by adoptive immunotherapy in combination with chemoradiotherapy. Oral Oncol. 34:1998;105-111.
24. Eichner R., Sun T.T., Aebi U. The role of keratin subfamilies and keratin pairs in the formation of human epidermal intermediate filaments. J. Cell Biol. 102:1986;1767-1777.
25. Gibson D.F.C., Ratnam A.V., Bikle D.D. Evidence for separate control mechanisms at the message, protein and enzyme activation levels for transglutaminase during calcium-induced differentiation of normal and transformed human keratinocytes. J. Invest. Dermatol. 106:1996;154-161.
26. Ikuta T., Chida K., Tajima O., et al. Cholesterol sulfate, a novel activator for the eta isoform of protein kinase C. Cell Growth Diff. 5:1994;943-947.
27. Chang E.H., Jang Y.J., Hao Z. Restoration of the G1 checkpoint and the apoptotic pathway mediated by wildtype p53 sensitizes squamous cell carcinoma of the head and neck to radiotherapy. Arch. Otolaryngol. Head Neck Surg. 123:1997;507-517.
28. Ueda M., Kumagai K., Ueki K., Inoki C., Orino I., Ueki M. Growth inhibition and apoptotic cell death in uterine cervical carcinoma cells induced by 5-fluorouracil. Int. J. Cancer. 71:1997;668-674.
29. Sanchez-Prieto R., Quintanilla M., Cano A., et al. Carcinoma cell lines become sensitive to DNA-damaging agents by the expression of the adenovirus E1A gene. Oncogene. 13:1996;1083-1092.
30. Sato M., Harada K., Yoshida H. Induction of differentiation and apoptosis and LeY antigen expression by treatment with 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone (vesnarinone) in a human salivary cancer cell line. Acta Histochem. Cytochem. 27:1994;591-599.
31. Kawamata H., Nakashiro K., Uchida D., et al. Induction of TSC-22 by treatment with a new anticancer drug, vesnarinone, in a human salivary gland cancer cell. Br. J. Cancer. 77:1988;71-78.
32. Osaki T., Tatemoto Y., Yoneda K., Yamamoto T. Tumorigenicity of cell lines established from oral squamous cell carcinoma and its metastatic lymph nodes. Oral Oncol. Eur. J. Cancer. 30B:1994;296-301.
33. Sherr C.J. G1 phase progression: cycling on cue. Cell. 18:1994;547-550.
34. Sherr C.J. Cancer cell cycles. Science. 274:1996;1672-1677.
35. Datto M.B., Li Y., Panus J.F., Howe D.J., Xiong Y., Wang X.-F. Transforming growth factor ( induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl. Acad. Sci. USA. 92:1995;5545-5549.
36. Datto M.B., Yu Y., Wang X.-F. Functional analysis of the transforming growth factor ( responsive elements in the WAF/Cip1/p21 promoter. J. Biol. Chem. 270:1995;28623-28628.
37. Ross J. mRNA stability in mammalian cells. Microbiol. Rev. 59:1995;423-450.
38. Li X.-S., Rishi A.K., Shao Z.-M., et al. Posttranscriptional regulation of p21WAF/CIP1 expression in human breast carcinoma cells. Cancer Res. 56:1996;5055-5062.
39. Sun T.T., Green H. Differentiation of the epidermal keratinocyte in cell culture: formation of the cornified envelope. Cell. 9:1976;511-521.
40. Yuspa S.H., Kilkenny A.E., Steinert P.M., Roop D.R. Expression of murine epidermal differentiation markers is tightly regulated by restricted extracellular calcium concentrations in vitro. J. Cell Biol. 109:1989;1207-1217.
41. Pillai S., Bikle D.D., Mancianti M.L., Cline P., Hincenbergs M. Calcium regulation of growth and differentiation of normal human keratinocytes: modulation of differentiation competence by stages of growth and extracellular calcium. J. Cell. Physiol. 143:1990;294-302.
42. Nair S.A., Nair M.B., Jayaprakash P.G., Rajalekshmy T.M., Nair M.K., Pillai M.R. Involucrin and tumor progression in the uterine cervix. Pathobiology. 64:1996;333-338.
43. Herzinger T., Wolf D.A., Eick D., Kind P. The pRb-related protein p130 is a possible effector of transforming growth factor beta 1 induced cell cycle arrest in keratinocytes. Oncogene. 10:1995;2079-2084.
44. Malliri A., Yeudall W.A., Nikolic M., Crouch D.H., Parkinson E.K., Ozanne B. Sensitivity to transforming growth factor beta 1-induced growth arrest is common in human squamous cell carcinoma cell lines: c-MYC downregulation and p21 waf1 induction are important early events. Cell Growth Diff. 7:1996;1291-1304.